clopidogrel (SR25990)

DRUG6 trials

Conditions

Acute Coronary SyndromesArteriosclerosisBlood Platelet DisordersCongenital Heart DefectsHeart Defects, CongenitalMyocardial InfarctionPeripheral Arterial Disease (PAD)Stable Angina

Phase 2

Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)

CompletedNCT00115375

SanofiBlood Platelet Disorders, Congenital Heart Defects

Start: 2004-01-31End: 2006-04-30Updated: 2009-03-25

Phase 3

Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

CompletedNCT00050817

SanofiArteriosclerosis

Start: 2002-10-31End: 2005-08-31Updated: 2012-04-23

Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation

CompletedNCT00396877

SanofiHeart Defects, Congenital

Start: 2006-11-30End: 2010-02-28Updated: 2014-10-24

Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction

CompletedNCT00714961

SanofiAcute Coronary Syndromes

Start: 2003-02-28End: 2005-01-31Updated: 2009-03-25

Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being Planned

CompletedNCT00821834

SanofiMyocardial Infarction, Stable Angina

Start: 2008-12-31End: 2010-08-31Updated: 2011-07-26

Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease

CompletedNCT00862420

SanofiPeripheral Arterial Disease (PAD)

Start: 2009-02-28End: 2011-05-31Updated: 2012-07-17

Circulation Cardiovascular Quality and Outcomes2014-10-01105 citations

Clopidogrel in Infants with Systemic-to-Pulmonary-Artery Shunts

New England Journal of Medicine2013-06-1971 citations

The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study.

2012-03-2668 citations

Clopidogrel for Atherothrombotic Event Management in Patients with Peripheral Arterial Disease (COOPER) Study: Safety and Efficacy of Clopidogrel versus Ticlopidine in Japanese Patients.

2012-01-0110 citations

Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.

2010-06-01169 citations

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.

2007-04-11516 citations

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

2006-03-121704 citations

clopidogrel (SR25990)

Sponsors

Conditions

Phase 2

Phase 3

Related Papers